Combination therapy with anti-HIV-1 antibodies maintains viral suppression (Q59090059)

Yehuda Z Cohen

11

0 references

Gerd Fätkenheuer

32

Gerd Fätkenheuer

0 references

Michel C. Nussenzweig

36

Michel C Nussenzweig

0 references

Georgia D. Tomaras

29

Georgia D Tomaras

0 references

Michael S Seaman

33

Thiago Yukio Kikuchi Oliveira

Michael S Seaman

0 references

9

Thiago Y Oliveira

0 references

Lilian Nogueira

3

Lilian Nogueira

0 references

Florian Klein

34

Florian Klein

0 references

Julio C Cesar Lorenzi

10

Julio C C Lorenzi

0 references

Irina Shimeliovich

22

Irina Shimeliovich

0 references

Roy M Gulick

30

Roy M Gulick

0 references

Clara Lehmann

7

Clara Lehmann

0 references

Henning Gruell

2

Henning Gruell

0 references

Maike Schlotz

20

Maike Schlotz

0 references

Marina Caskey

35

Marina Caskey

0 references

Theodora K Karagounis

14

Theodora Karagounis

0 references

Cecilia Unson-O'Brien

17

Cecilia Unson-O'Brien

0 references

Tim Kümmerle

13

Tim Kümmerle

0 references

Christoph Wyen

12

Christoph Wyen

0 references

Joy A Pai

4

Joy A Pai

0 references

Allison Butler

5

Allison L Butler

0 references

Katrina G Millard

6

Katrina Millard

0 references

Jill Horowitz

26

Jill Horowitz

0 references

author name string

Pilar Mendoza

1

0 references

Isabelle Suárez

8

0 references

Ching-Lan Lu

15

0 references

Lisa Handl

16

0 references

Roshni Patel

18

0 references

Carola Ruping

19

0 references

Maggi Witmer-Pack

21

0 references

Gisela Kremer

23

0 references

Eleonore Thomas

24

0 references

Kelly E Seaton

25

0 references

Anthony P West

27

0 references

Nico Pfeifer

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.

31

0 references

language of work or name

English

0 references

publication date

September 2018

0 references

published in

Nature

0 references

volume

561

0 references

issue

7724

0 references

page(s)

479-484

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Early antibody therapy can induce long-lasting immunity to SHIV

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Progress toward active or passive HIV-1 vaccination

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Dissecting How CD4 T Cells Are Lost During HIV Infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV reservoirs: what, where and how to target them

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV-1 integration landscape during latent and active infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Unravelling the mechanisms of durable control of HIV-1.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

A method for identification of HIV gp140 binding memory B cells in human blood

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Clustal W and Clustal X version 2.0

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

High throughput functional analysis of HIV-1 env genes without cloning

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

30 November 2018

Recombination in HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6166473

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

30 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41586-018-0531-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41586-018-0531-2